Select Publications
Journal articles
2021, 'MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer', Frontiers in Oncology, 11, http://dx.doi.org/10.3389/fonc.2021.777867
,2021, 'The management of HER2-positive early breast cancer: Current and future therapies', Asia-Pacific Journal of Clinical Oncology, 17, pp. 3 - 12, http://dx.doi.org/10.1111/ajco.13655
,2021, 'Case Report: Paclitaxel-Induced Pneumonitis in Early Breast Cancer: A Single Institution Experience and Review', Frontiers in Oncology, 11, http://dx.doi.org/10.3389/fonc.2021.701424
,2020, 'Window of opportunity treatment in breast cancer', ANZ Journal of Surgery, 90, pp. 34 - 40, http://dx.doi.org/10.1111/ans.15487
,2017, 'The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis', Oncotarget, 8, pp. 23099 - 23109, http://dx.doi.org/10.18632/oncotarget.15485
,2015, 'Prematurity reduces the severity and need for treatment of neonatal abstinence syndrome', Acta paediatrica (Oslo, Norway : 1992), 104, pp. e188 - e194, http://dx.doi.org/10.1111/apa.12910
,2014, 'Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis', Prostate Cancer and Prostatic Diseases, http://dx.doi.org/10.1038/pcan.2014.10
,2013, 'Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants', Journal of Paediatrics and Child Health, 49, pp. 746 - 753, http://dx.doi.org/10.1111/jpc.12264
,